European Medicines Agency publishes list of human medicines under evaluation
The list includes the international non-proprietary names (INNs) and therapeutic areas for all new innovative medicines under evaluation, along with information on the type of salt, ester or derivative of the active substance. For generic and biosimilar medicines, it includes the INN and therapeutic area. The list only includes medicines whose applications have been validated.
The Agency will update this information every month following the plenary meeting of the CHMP.
This initiative forms part of the drive towards increased transparency on its activities by the Agency and other European regulatory authorities. It follows the publication of recommendations on transparency of ongoing evaluations adopted by the European Medicines Agency and the Heads of Medicines Agencies in November 2010.
INNs or generic names are the globally recognised names used to identify active ingredients in pharmaceuticals. INNs are selected by the World Health Organization (WHO).
- European Medicines Agency to publish information on ongoing medicine evaluations (17/02/2012)
- Medicines under evaluation
- Applications for new human medicines under evaluation by the CHMP: March 2012 (02/03/2012)
- Heads of Medicines Agencies/European Medicines Agency recommendations on transparency: Recommendations on release of information with regard to new applications for medicinal products before and after opinion or decision on granting of a marketing authorisation (06/12/2010)